8095.T),">
Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on February 20, 2026. It represents a primary source document for Japanese Dividends sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: February 20, 2026 Astena Holdings Co.,Ltd. [8095.T] TOKYO, Feb 20 (Pulse News Wire) -- Astena Holdings Co., Ltd. (8095.T), represented by Chairman and CEO Satoshi Setoguchi, announced today that it has received dividends totaling ¥458 million from its wholly-owned subsidiary Spera Pharma Co., Ltd. The dividend resolution was made on February 20, 2026, during a shareholders' meeting held within the subsidiary company. The actual transfer of funds is scheduled for Fe